Acetylcarnitine is a type of carnitine. It helps your body use fats for energy. It's sometimes used to help with certain types of muscle problems or fatigue, but more research is needed to know exactly how it works.
Every report comes from a Lived member, sent anonymously.
Have you tried Acetylcarnitine for Diabetic Neuropathies?
Acetylcarnitine, also called acetyl-L-carnitine or ALCAR, is a form of carnitine, a natural substance the body makes and also gets from foods, especially red meat. In the United States it is sold as a dietary supplement and has not been approved by the Food and Drug Administration (FDA) as a drug for any condition. In Italy it is an approved medicine for certain kinds of nerve pain. People most often take it for peripheral neuropathy, nerve damage that causes burning, tingling or numbness, usually in the feet and hands, and most studies have been in neuropathy caused by diabetes. It has also been studied for low mood, for Alzheimer's disease and for hepatic encephalopathy (confusion caused by advanced liver disease), and it is marketed for energy and weight loss. The evidence for all of these uses is limited. For Alzheimer's disease, trials showed no benefit on objective tests of memory or daily function, and reviewers found no evidence to recommend it for routine use. Acetylcarnitine is not the same as prescription levocarnitine (L-carnitine), which doctors use to treat diagnosed carnitine deficiency.
Inside cells, carnitine works as a shuttle that carries fatty acids into the mitochondria, the parts of the cell that burn fuel for energy. Acetylcarnitine is carnitine with an acetyl group attached, which helps it move into cells, and the body converts the two forms back and forth as needed. Laboratory and animal research suggests acetylcarnitine may also protect nerve cells and help damaged nerves regrow, which is why it has been tried for neuropathy. These effects have not been shown to explain any benefit in people. When it is swallowed, much of it is converted back to plain L-carnitine in the wall of the gut before it reaches the bloodstream.
Acetylcarnitine comes as capsules, tablets and powders. There is no officially established dose for any condition. In clinical trials for nerve pain, adults generally took 1,500 to 3,000 mg a day for 6 to 12 months. In the diabetic neuropathy trials, doses of 1,500 mg a day or less worked no better than placebo, and any benefit appeared only at higher doses. Anyone considering it for a medical condition should agree on a dose and a trial period with their clinician rather than taking it indefinitely without a plan.
In clinical trials, acetylcarnitine was usually well tolerated. The side effects that led some people to stop taking it were digestive upset, headache and tingling in the face. Many studies reported side effects poorly, and reviewers have concluded that the evidence is too uncertain to judge its safety with confidence, particularly over long periods.
People receiving chemotherapy should not take acetylcarnitine to prevent nerve damage. In a large trial of women receiving taxane chemotherapy (a common type of chemotherapy for breast cancer), those taking 3,000 mg a day had more nerve damage after 24 weeks than those taking a placebo. The American Society of Clinical Oncology (ASCO) discourages its use for this purpose. Anyone being treated for cancer should check with their oncology team before starting it. Because swallowed acetylcarnitine is largely converted to L-carnitine, which counteracts the action of thyroid hormone in the body's tissues, people taking thyroid hormone such as levothyroxine, or being treated for a thyroid condition, should mention it to their clinician. A published case describes a man with bipolar disorder whose mania returned after he started acetylcarnitine for weight loss and settled after he stopped it. People with bipolar disorder should discuss it with their clinician first, and contact them promptly if they notice signs of mania, such as needing much less sleep, racing thoughts or feeling unusually wired or irritable.
Acetylcarnitine is not a quick fix. In the neuropathy trials, pain was measured after 6 to 12 months of daily use. Across those trials, the average improvement over placebo was about a fifth of a person's starting pain score, but the trials were small, several were funded by manufacturers, and reviewers were very uncertain whether it truly reduces pain. Many people may notice no change. A sensible approach is to decide with a clinician what improvement to look for and how long to try it, to keep using treatments with stronger evidence, and to stop if there is no meaningful change. Because it is a supplement, it is worth listing it alongside other medicines at every appointment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Acetylcarnitine, what you've noticed, or ask the community a question.